Showing results (671-680 of 1,296) with videos related to
Sort By:
Pageof 130
Nature Reviews. Drug Discovery|April 7, 2010
Anticancer drug development: the grand challengesWilliam N HaitNature Reviews. Drug Discovery|July 31, 2010
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapyKlaus StrebhardtNature Reviews. Drug Discovery|June 10, 2010
Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 yearsM Miles Braun, Sheiren Farag-El-Massah, Kui Xu, et al.Nature Reviews. Drug Discovery|October 2, 2010
Microtubule-binding agents: a dynamic field of cancer therapeuticsCharles Dumontet, Mary Ann JordanNature Reviews. Drug Discovery|October 2, 2010
Integrins as therapeutic targets: lessons and opportunitiesDermot Cox, Marian Brennan, Niamh MoranNature Reviews. Drug Discovery|September 18, 2010
Developing drug prototypes: pharmacology replaces safety and tolerability?Adam F CohenNature Reviews. Drug Discovery|December 2, 2010
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discoveryDennis A Smith, Li Di, Edward H KernsNature Reviews. Drug Discovery|December 2, 2010
Targeting non-malignant disorders with tyrosine kinase inhibitorsFriedrich Grimminger, Ralph T Schermuly, Hossein A GhofraniNature Reviews. Drug Discovery|December 15, 2010
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targetsLynn Bedford, James Lowe, Lawrence R Dick, et al.Nature Reviews. Drug Discovery|May 1, 2010
Inhaled aztreonamBrian P O'Sullivan, Uma Yasothan, Peter KirkpatrickPageof 130